TQA3038 Injection

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQA3038 Injection, covering 2024-06-11 to 2024-06-11. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B [Phase 1, Phase 2]

See pricing